Leadership Team 2016-2017
President
Eric Shi, Ph.D. Investigator, GSK, Waltham, MA
Chairman of the Board
Shiwen Lin, Ph.D. Director, Process & Analytical Technologies, Agenus, Inc. Lexington, MA
President-Elect (2017-2018)
Kevin Fang, Ph.D. Sr. Director of Medicinal Chemistry, Sunovion Pharmaceuticals Inc., Marlborough, MA
Vice President
Jian Shao, MBA, Founder and CEO, Sword Therapeutics
Bo Ying, Ph.D. Director, Formulation, PNA Innovations, Woburn, MA
Vice President of Finance
Zhendong Zhu, Ph.D. Principal Investigator, Celgene Avilomics Research, Bedford, MA
General Manager of Public Relations
Qingqing Cao, Ph.D. Sr Program manager, Insulet Corporation, Billerica, MA
General Manager of Operations
Ellen Fan, MSc., Ph.D. Candidate, Senior Scientist, Smith & Nephew, Andover, MA
Treasurer
Liping Zhou, Ph.D. Senior Scientist, Ipsen Biosciences., Cambridge, MA
Legal Counsel
Fred Gilman, Attorney at Law, Lynch, DeSimone & Nylen, LLP, Boston, MA
Executive Committee Members
Lan Cao, Ph.D. Director, Unum Therapeutics, Cambridge, MA
Qinglin Che, Ph.D. Senior Scientist, Tetraphase Pharmaceuticals, Inc., Watertown, MA
Yin Chen, Ph.D. Director of Business Development at Accelagen
Shujia Daniel Dai, Ph.D. Principal Reserach Investigator, Sanofi-Aventis
Henry Gu, J.D. Intellectual Property Counsel, Agios Pharmaceuticals, Cambridge, MA
Jianfeng Jeff Hang, Ph.D. Director of Quality Systems, Makromed, Inc., Salem, NH
Jo Lee, M.Ec. Founder, Somebusiness, Inc.
Hao Howard Li, Ph.D. MBA, Cambridge Site Head, Novartis Knowledge Center, Novartis, Cambridge, MA
Jing Jeannie Li, Ph.D. Senior Scientist, Pfizer, Cambridge, MA
Carrie Liu, Ph.D. Associate Director of Technical Operation, Analytical, Vertex Pharmaceuticals, Boston, MA
Sue Ma, M.D. Scientist II, Novartis Institute of BioMedical Research, Cambridge, MA
Xue Shui, Associate Scientist I, Dicerna Pharmaceuticals, Cambridge, MA
Yueming Wang, MBA Board Member and CEO of Zhonguan Pharmaceutical Co. Ltd., Beijing, China
Zhigang Wang, Ph.D. Sr. Principal Scientist, Celgene Avilomics Research, Bedford, MA
Li Xing, Ph. D. Senior Director, Wuxi AppTec, Boston, MA
Wendy Yang, MBA, Manager, R&D Operational Planning and Capacity Management - CMC, Sanofi US, Waltham, MA
Chunxiao Yu, Ph.D. Postdoctoral Research Fellow, Harvard Medical School
Jingzhong Jeff Zhang, Ph.D. Senior Scientist, Medica Corp
Wei Zhang, Ph.D. Staff Scientist, Siemens Healthcare Diagnostics, Norwood , MA
Youxin Zhang, Ph.D. Managing Consultant, Navigant Consulting, Boston, MA
Xiaoyong Zhao, Ph.D. Senior Scientist, Momenta
Board of Directors
Zhihong Chen, Ph.D. Past President (2011-2012)
Chaoyang Dai, Ph.D. Past president (2010-2011), President, Boston Biosolutions
Jun Han, Ph.D. Founding President, CEO, SOTA International LLC, Boston, MA
Susan Qu, Ph.D. MBA, Past president (2015-2016), External Manufacturing Integrated Risk Manager, Genzyme Corporation, a division of Sanofi, Framingham, MA
Lixin Shen, Ph.D. President and CEO, Wuxi Howfond Biopharma Co., Ltd., Jiangsu, China
Zhao-Kui (ZK) Wan, Ph.D. Past-President (2009-2010), Head of Chemistry and a member of leadership team at Johnson & Johnson's Asian Pacific Discovery Center in Shanghai, China
Yihan Wang, Ph.D. President, Shenzhen TargetRx, Inc., Shenzhen, China
Erxi Wu, Ph.D. Director, Neuro-oncology Research Center, Baylor Scott & White Health; Associate Prof., Texas A&M University
Junjun Wu, Ph.D. Past President (2007-2009), CEO, WuXi AllNature Biotech LLC, Jiangsu, China
Xiang Yang Yu, Ph.D. Past president (2013-2014), Program Manager, Accellient Partners LLC, Waltham, MA
Zhiyong Yang, Ph.D. Past president (2014-2015), Senior Principal Scientist, Pfizer, Cambridge, MA
Philip Zhang, Ph. D., J. D. Past President (2012-2013), Co-Founder and Chairman, Milstein Zhang & Wu LLC, Newton, MA
CABA Advisors
Youssef Bennani, Ph.D. Site Head, Vertex Pharmaceuticals Inc.-Canada
Tim Clackson, Ph.D. President of Research and Development and Chief Scientific Officer, Ariad Pharmaceuticals Inc., Cambridge, MA
Yuan-Hua Ding, Ph.D. Senior Director & Head of External R&D Innovation - Asia, Pfizer
Pierre Dodion, M.D., MBA, Sr. VP, Corporate Development, Ariad Pharmaceuticals Inc., Cambridge, MA
Chen Li, Ph.D. Chief Executive Officer, Hua Medicine, Inc., Shanghai, China
Luke Li, Ph.D. Exec Director, Head of Global Biotherapeutic Technologies, Bio-Innovation, Pfizer
Shi Li, Ph.D. CEO, Zerun Biotechnology, Shanghai, CHINA
Yuanli Liu, Ph.D. Director of China Initiative, Sr. Lecturer on International Health, Dept. of Global Health and Population, Harvard School of Public Health
Dawei Ma , Ph.D. Professor, Shanghai Institute of Organic Chemistry, Shanghai, China
Tarek Mansour, Ph.D. EVP of Research & Development, Xenon Pharmaceuticals Inc., Vancouver, Canada
Tse Ping, Chairman, Sino Biopharmaceutical Ltd., Beijing, China
John Piwinski, Ph.D. Principal, JJPiwinski Pharma Consulting, LLC, New York, NY
Steve Projan, Ph.D. Sr. V.P. R&D, Innovative Medicines Head of Infectious Diseases & Vaccines, MedImmune, Gaithersburg, MD
Tomi Sawyer, Ph.D. Chief Scientific Officer and Senior Vice-President, Aileron Therapeutics, Cambridge, MA
Liming Shao, Ph.D. Professor, Fudan University, Shanghai, China
Suvit Thaisrivongs, Ph.D. Vice President, Pfizer, Inc., Cambridge. MA
Roger Tung, Ph.D. CEO and President, Concert Pharmaceuticals, Lexington, MA
Yibin Xiang, Ph.D. CSO, Sanhome Pharma
Sunny Xie, Ph.D. Professor, Northeastern University
Gangfeng Xu, Ph.D. Divisional Vice President, Corporate Licensing & Acquisitions at Abbott Laboratories
Steve Yang, Ph.D. Executive VP & COO, Wuxi Apptec
Howard Yuwen, Ph.D. Co-founder & VP Corporate Development & Regulatory Affairs, Genesun Pharmaceuticals
Zhaohui Sunny Zhou, Ph.D. Associate Professor, Department of Chemistry and Chemical Biology and Faculty Fellow, Barnett Institute of Chemical and BiologicalAnalysis, Northeastern University
CABA Thank the dedicated service from the retired EC members: Ze Tian and Jinbo Lee
